News

Pacritinib taken off FDA clinical hold.

MPN News | 1/5/2017

CTI BioPharma will start a new trial, PAC203 for Myelofibrosis

Read More

Phase 2 study combines Ruxolitinib and Decitabine for people with MPN

MPN News | December 21, 2016

Phase 2 study combines Ruxolitinib and Decitabine for people with MPN

Read More

Share your experience with Essential Thrombocythemia (ET) to help shape the future of treatment

MPN News | 12/12/2016

This research study is by QuintilesIMS (sponsored by Incyte Corporation) Background QuintilesIMS Global Services, a worldwide consulting firm, is conducting a research study to better understand the experience of ET patients. QuintilesIMS plans to interview patients who have been diagnosed with ET one‐on‐one over the phone. QuintilesIMS is looking for interested people to share what they have gone through since being diagnosed with ET. Purpose The overall purpose of the study is to learn which symptoms of ET are the most common, and how these symptoms typically affect the lives of patients like you who live with the disease. This understanding may help improve how the patient’s experience is accounted for in clinical trials that measure the effect of disease treatments. It also may help patients and their families by highlighting the consequences of the disease that most need greater attention, possibly leading to the development of new programs and support services.

Read More

MPN highlights from ASH's annual meeting

MPN News | December 12, 2016

MPN highlights from ASH's annual meeting

Read More

Katya Ravid makes discovery on using MRI to detect myelofibrosis

MPN News | November 21, 2016
Read More

New NCCN Guidelines outline diagnosis, treatment strategies for MPNs

MPN News | September 30, 2016

NCCN Guidelines document evidence-based consensus-driven management to ensure that all patients receive preventive, diagnostic, treatment, and supportive care services that are most likely to lead to optimal outcomes.

Read More

Share your experience-myMPN

MPN News | 9/30/2016

myMPN is the first ever registry for all patients with MPNs. It will be launched in early 2017 and we hope you’ll join in our effort to gather patient information about life with ET, PV and MF. The goals of myMPN are:

Read More

CTI reports topline data for PERSIST-2 in the hopes of lifting FDA hold in coming months.

MPN News | August 30th, 2016

CTI BIOPHARMA Announces top-line results from PERSIST-2 Phase 3 trial of Pacritnib for high-risk patients with advanced myelofibrosis

Read More

ASH announces seventh-round bridge grant recipients

MPN News | July 21st

MPN Research Foundation congratulates our MPN Challenge grantees Zhijian Qian, a PhD from the University of Illinois at Chicago and Ann Mullally,a MD at The Brigham and Women's Hospital for receiving the 2016 ASH Bridge Grant.

Read More
MPN News | March 1, 2014
Read More

Anti-fibrotic drug PRM-151 recruiting MF patients across the country

MPN News | July 4, 2016

The PROMOTE site has information on their clinical trial including which sites are actively recruiting people who have myelofibrosis.

Read More

Stanford and 23andMe partner on MPN

MPN News | July 5, 2016

Reported in Blood, 726 people with Polycythemia vera, essential thrombocythemia and myelofibrosis were compared to a control group.

Read More
MPN News
Read More

Vice President Joe Biden addresses the 2016 ASCO audience

MPN News | June 7, 2016

The Cancer Moonshot is a new push for more teamwork in cancer research and application of innovation.

Read More

MPN updates from ASCO 2016

MPN News | June 8, 2016

Updates on clinical trials and research news for PV, ET and MF.

Read More

Check our News - Archive for older news.

Get updates on MPN patients and research breakthroughs.

What are the latest developments in MPN Research?